The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

Clinical trial NCT05786066 · RECRUITING

Trial details

NCT number: NCT05786066
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder Major Depressive Disorder Bipolar Disorder Post Traumatic Stress Disorder Suicidal Ideation

Start date: 2023-04-03
Primary completion: 2033-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.